IL24 and viral infectious disease: To determine whether the antitumor efficacy of ZD55-IL-24 in A375-bearing immunocompromised mouse model depended mainly on the direct killing pathway rather than antitumor immunity pathway, we first examined the viral infection and exogenous IL-24 expression in A375 cells in vitro.